Dr. Gregory Robbert Vorhoff, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 200 West Esplanade Ave, Suite 405, Kenner, LA 70065 Phone: 504-305-3500 Fax: 504-305-3502 |
Sanjay Kamboj, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 200 West Esplanade Ave, Ste 205, Lsuhn Multispecialty Clinic/s. Kabboj, Kenner, LA 70065 Phone: 504-412-1705 Fax: 504-412-1726 |
Barry L. Riemer, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: Lsu Healthcare Network - Orthopedics, 200 West Esplanade Avenue, #500, Kenner, LA 70065 Phone: 504-468-6535 |
Dr. Sergio Eduardo Schabelman, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 200 West Esplanade Ave, Suite 405, Kenner, LA 70065 Phone: 504-305-3500 Fax: 504-305-3502 |
News Archive
Active Biotech and Ipsen today presented overall survival (OS) data from the tasquinimod Phase II study in chemotherapy-naïve metastatic castrate resistant prostate cancer (CRPC) at the scientific conference "2012 ASCO Annual Meeting" held in Chicago (USA).
AmpliPhi Biosciences Corporation, a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that the company has received positive feedback, via written response, from the U.S. Food and Drug Administration regarding its development plans for AB-PA01, without the need for a Type B Pre-IND meeting.
Researchers at University of California San Diego School of Medicine have begun a pilot clinical trial to test the efficacy of using ultrasound to stimulate the spleen and reduce COVID-19-related inflammation, decreasing the length of hospital stays.
Coming week on 6th of May, the National Institutes of Health, NIH, would open enrollment for the "All for Us" research program. This program would be one of the first steps in revolutionizing individualized prevention of disease as well as diagnosis and treatment.
Those working inside the Trump administration are getting so frustrated with the response to the COVID-19 pandemic that they are going public.
› Verified 4 days ago